Pfizer's Q1 2026 Earnings: Beating Estimates with New Drugs episode artwork

EPISODE · May 5, 2026 · 1 MIN

Pfizer's Q1 2026 Earnings: Beating Estimates with New Drugs

from The Daily News Now! Business

Pfizers Q1 2026 earnings soar, beating estimates with $14.45 billion revenue, up 5% YoY. Earnings per share strong despite COVID impact. Newer drugs and acquisitions drive 22% operational growth. Oncology and primary care lead with 7% and 8% growth respectively. Pfizer maintains full-year targets, pivoting from pandemic peaks with promising new medications. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/d4f2cdde2d03c6d3

NOW PLAYING

Pfizer's Q1 2026 Earnings: Beating Estimates with New Drugs

0:00 1:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on May 5, 2026.

What is this episode about?

Pfizers Q1 2026 earnings soar, beating estimates with $14.45 billion revenue, up 5% YoY. Earnings per share strong despite COVID impact. Newer drugs and acquisitions drive 22% operational growth. Oncology and primary care lead with 7% and 8%...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!